In addition, the current findings align with previous research that Trop‐2 is overexpressed in CRPC, and targeting Trop‐2 induced dose‐dependent inhibition of cell growth in Trop‐2 expressing cancer cells.17 The gene discussed is TACSTD2; the disease is cancer.